Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Adverum Biotechnologies, Inc. | aavl-ex211_15.htm |
| EX-10.39 - EX-10.39 - Adverum Biotechnologies, Inc. | aavl-ex1039_1359.htm |
| EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc. | aavl-ex311_13.htm |
| EX-10.38 - EX-10.38 - Adverum Biotechnologies, Inc. | aavl-ex1038_1358.htm |
| EX-32.1 - EX-32.1 - Adverum Biotechnologies, Inc. | aavl-ex321_11.htm |
| 10-K - 10-K - Adverum Biotechnologies, Inc. | aavl-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-199296 and No. 333-203398 on Form S-8 of our report dated March 03, 2016, relating to the consolidated financial statements of Avalanche Biotechnologies, Inc. and its subsidiary appearing in this Annual Report on Form 10-K of Avalanche Biotechnologies, Inc. for the year ended December 31, 2015.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
March 3, 2016